What is Stelfonta? A Breakthrough in Non-Surgical Tumor Treatment
•
3 min read
In a pivotal clinical trial, a single injection of Stelfonta led to complete tumor resolution in 75% of treated dogs within 28 days. What is Stelfonta? This injectable medication, also known as tigilanol tiglate, is a veterinary treatment option for certain non-metastatic mast cell tumors (MCTs) in dogs, offering a non-surgical alternative for hard-to-reach or difficult-to-excise tumors.
